Selected research
Industry Growth & Trends
Global CRO in Clinical Trials Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global CRO in Clinical Trials market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the CRO in Clinical Trials market include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, MedPace and Wuxi AppTec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global CRO in Clinical Trials market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The CRO in Clinical Trials market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global CRO in Clinical Trials market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to CRO in Clinical Trials.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global CRO in Clinical Trials market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
CRO in Clinical Trials Market by Company
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
MedPace
Wuxi AppTec
CRO in Clinical Trials Segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
CRO in Clinical Trials Segment by End User
Pharmaceutical
Bio-pharm
Others
CRO in Clinical Trials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRO in Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRO in Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRO in Clinical Trials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of CRO in Clinical Trials companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Phase I Trial
- Phase II Trial
- Phase III Trial
- Phase IV Trial
Applications
- Pharmaceutical
- Bio-pharm
- Others
Companies covered
- Labcorp
- IQVIA
- Parexel
- Syneos Health
- PRA Health Sciences
- PPD
- ICON
- MedPace
- Wuxi AppTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global CRO in Clinical Trials Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global CRO in Clinical Trials Market Size by Region (2021-2032)
- 1.4.1 Global CRO in Clinical Trials Market Size by Region (2021-2026)
- 1.4.2 Global CRO in Clinical Trials Market Size by Region (2027-2032)
- 1.5 Key Regions CRO in Clinical Trials Market Size (2021-2032)
- 1.5.1 North America CRO in Clinical Trials Market Size Growth Rate (2021-2032)
- 1.5.2 Europe CRO in Clinical Trials Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific CRO in Clinical Trials Market Size Growth Rate (2021-2032)
- 1.5.4 South America CRO in Clinical Trials Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa CRO in Clinical Trials Market Size Growth Rate (2021-2032)
2 CRO in Clinical Trials Market by Type
- 2.1 Type Introduction
- 2.1.1 Phase I Trial
- 2.1.2 Phase II Trial
- 2.1.3 Phase III Trial
- 2.1.4 Phase IV Trial
- 2.2 Global CRO in Clinical Trials Market Size by Type
- 2.2.1 Global CRO in Clinical Trials Market Size Overview by Type (2021-2032)
- 2.2.2 Global CRO in Clinical Trials Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global CRO in Clinical Trials Market Size Forecasted by Type (2027-2032)
- 2.3 Global CRO in Clinical Trials Market Size by Regions
- 2.3.1 North America CRO in Clinical Trials Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe CRO in Clinical Trials Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific CRO in Clinical Trials Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America CRO in Clinical Trials Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa CRO in Clinical Trials Market Size Breakdown by Type (2021-2026)
3 CRO in Clinical Trials Market by End User
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical
- 3.1.2 Bio-pharm
- 3.1.3 Others
- 3.2 Global CRO in Clinical Trials Market Size by End User
- 3.2.1 Global CRO in Clinical Trials Market Size Overview by End User (2021-2032)
- 3.2.2 Global CRO in Clinical Trials Historic Market Size Review by End User (2021-2026)
- 3.2.3 Global CRO in Clinical Trials Market Size Forecasted by End User (2027-2032)
- 3.3 Global CRO in Clinical Trials Market Size by Regions
- 3.3.1 North America CRO in Clinical Trials Market Size Breakdown by End User (2021-2026)
- 3.3.2 Europe CRO in Clinical Trials Market Size Breakdown by End User (2021-2026)
- 3.3.3 Asia-Pacific CRO in Clinical Trials Market Size Breakdown by End User (2021-2026)
- 3.3.4 South America CRO in Clinical Trials Market Size Breakdown by End User (2021-2026)
- 3.3.5 Middle East and Africa CRO in Clinical Trials Market Size Breakdown by End User (2021-2026)
4 Global Market Dynamics
- 4.1 CRO in Clinical Trials Industry Trends
- 4.2 CRO in Clinical Trials Industry Drivers
- 4.3 CRO in Clinical Trials Industry Opportunities and Challenges
- 4.4 CRO in Clinical Trials Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by CRO in Clinical Trials Revenue (2021-2026)
- 5.2 Global CRO in Clinical Trials Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global CRO in Clinical Trials Key Company Headquarters & Area Served
- 5.4 Global CRO in Clinical Trials Company, Product Type & Application
- 5.5 Global CRO in Clinical Trials Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global CRO in Clinical Trials Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 CRO in Clinical Trials Players Market Share by Revenue in 2025
- 5.6.3 2025 CRO in Clinical Trials Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Labcorp
- 6.1.1 Labcorp Company Information
- 6.1.2 Labcorp Business Overview
- 6.1.3 Labcorp CRO in Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Labcorp CRO in Clinical Trials Product Portfolio
- 6.1.5 Labcorp Recent Developments
- 6.2 IQVIA
- 6.2.1 IQVIA Company Information
- 6.2.2 IQVIA Business Overview
- 6.2.3 IQVIA CRO in Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 IQVIA CRO in Clinical Trials Product Portfolio
- 6.2.5 IQVIA Recent Developments
- 6.3 Parexel
- 6.3.1 Parexel Company Information
- 6.3.2 Parexel Business Overview
- 6.3.3 Parexel CRO in Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Parexel CRO in Clinical Trials Product Portfolio
- 6.3.5 Parexel Recent Developments
- 6.4 Syneos Health
- 6.4.1 Syneos Health Company Information
- 6.4.2 Syneos Health Business Overview
- 6.4.3 Syneos Health CRO in Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Syneos Health CRO in Clinical Trials Product Portfolio
- 6.4.5 Syneos Health Recent Developments
- 6.5 PRA Health Sciences
- 6.5.1 PRA Health Sciences Company Information
- 6.5.2 PRA Health Sciences Business Overview
- 6.5.3 PRA Health Sciences CRO in Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 PRA Health Sciences CRO in Clinical Trials Product Portfolio
- 6.5.5 PRA Health Sciences Recent Developments
- 6.6 PPD
- 6.6.1 PPD Company Information
- 6.6.2 PPD Business Overview
- 6.6.3 PPD CRO in Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 PPD CRO in Clinical Trials Product Portfolio
- 6.6.5 PPD Recent Developments
- 6.7 ICON
- 6.7.1 ICON Company Information
- 6.7.2 ICON Business Overview
- 6.7.3 ICON CRO in Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 ICON CRO in Clinical Trials Product Portfolio
- 6.7.5 ICON Recent Developments
- 6.8 MedPace
- 6.8.1 MedPace Company Information
- 6.8.2 MedPace Business Overview
- 6.8.3 MedPace CRO in Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 MedPace CRO in Clinical Trials Product Portfolio
- 6.8.5 MedPace Recent Developments
- 6.9 Wuxi AppTec
- 6.9.1 Wuxi AppTec Company Information
- 6.9.2 Wuxi AppTec Business Overview
- 6.9.3 Wuxi AppTec CRO in Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Wuxi AppTec CRO in Clinical Trials Product Portfolio
- 6.9.5 Wuxi AppTec Recent Developments
7 North America
- 7.1 North America CRO in Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America CRO in Clinical Trials Market Size by Country (2021-2026)
- 7.3 North America CRO in Clinical Trials Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe CRO in Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe CRO in Clinical Trials Market Size by Country (2021-2026)
- 8.3 Europe CRO in Clinical Trials Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific CRO in Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific CRO in Clinical Trials Market Size by Country (2021-2026)
- 9.3 Asia-Pacific CRO in Clinical Trials Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America CRO in Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America CRO in Clinical Trials Market Size by Country (2021-2026)
- 10.3 South America CRO in Clinical Trials Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa CRO in Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa CRO in Clinical Trials Market Size by Country (2021-2026)
- 11.3 Middle East & Africa CRO in Clinical Trials Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst